Novartis proposes takeover of Chiron
5th Sep 2005, 13:33 GMT
Novartis has made a proposal to the directors of Chiron Corporation to acquire all of the remaining outstanding shares that it does not already own. If accepted the deal would cost Novartis a total of $4.5 billion.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol